Chris Erickson, the founding general partner of Pangaea Ventures. See sector focus and contact routes.
Chris Erickson, the founding general partner of Pangaea Ventures, invests exclusively in early-stage and growth-stage hard-tech companies within advanced materials, chemistry, and biology to address planetary health challenges. His distinctive thesis focuses on backing smart entrepreneurs with breakthrough innovations that solve significant problems in large, emerging markets like energy, electronics, health, and sustainability. Notable portfolio companies include Redlen (medical imaging, acquired by Canon for >$400M), Aspect Biosystems (3D tissue printing), CarbonCure (CO2 concrete strengthening), and ESS (all-iron flow battery). While the firm targets seed, Series A, and growth equity, specific check sizes for Erickson individually are not publicly disclosed in the provided sources.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Phoenix.
Investors like Chris Erickson · Full investor directory · Investor access · Company funding database